Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Neonatal Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • cGMP CliniControl™ Products
      • Human Primary Cells
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
    • Engineered Human Cell Lines
      • hTERT-Modified hMSCs
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

Corneal Nerve Regeneration Via MSC-Derived EVs: Tissue Source and Culture Dimensionality Dictate miRNA Cargo and Therapeutic Efficacy

December 2025 Bioprinting, Bioprocessing, Cell Therapy, Exosomes / Extracellular Vesicles, Immunomodulation, Orthopedic, Pain, Tissue Engineering

Extracellular Vesicles From Mesenchymal Stromal Cells Modulate Inflammatory Responses on Feline Mixed Glia

July 2025 Bioprocessing, Cancer, Cell Therapy, Exosomes / Extracellular Vesicles, Immunomodulation, Pain

The proteomic landscape of extracellular vesicles derived from human intervertebral disc cells

November 2024 Bioprinting, Bioprocessing, Cell Therapy, Exosomes / Extracellular Vesicles, Pain, Tissue Engineering

A Bioactive Hydrogel Based on Notochordal Cell-Derived Matrix Stimulates Nucleus Pulposus Regeneration

October 2024 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Dermal and Wound, Exosomes / Extracellular Vesicles, MedTech, Devices, & Materials, Pain, Tissue Engineering

Strategies for the Codelivery of Osteoclasts and Mesenchymal Stem Cells in 3D-Printable Osteochondral Scaffolds

August 2024 Bioprinting, Bioprocessing, Blood, MedTech, Devices, & Materials, Orthopedic, Pain, Tissue Engineering

Development of an Allogeneic, Anti-Inflammatory Bone Marrow Stromal Cell Therapy for Chronic Low Back Pain Patients with Modic Type 1 Changes

March 2024 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Immunomodulation, Orthopedic, Pain, Tissue Engineering

Intervertebral disc cells from human back pain subjects exhibit TNFR1-mediated senescence and lack TNFR2-modulated repair capacity

February 2024 Bioprinting, Bioprocessing, Exosomes / Extracellular Vesicles, Immunomodulation, Pain, Tissue Engineering

Recent Advances in Extracellular Vesicle Engineering & Its Applications to Regenerative Medicine

December 2023 Bioprocessing, Exosomes / Extracellular Vesicles, Gene Editing, Genetic, Pain, Renal

Nested Biofabrication: Matryoshka-inspired Intra-embedded Bioprinting

October 2023 Bioprinting, Bioprocessing, Blood, Cancer, Cell Therapy, Clinical, Diabetes, MedTech, Devices, & Materials, Pain, Tissue Engineering

Differentiation State & Culture Conditions Impact Neural Stem/progenitor Cell-derived Extracellular Vesicle Bioactivity

June 2023 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Immunomodulation, Pain, Tissue Engineering
1 2 Next

Sidebar Navigation

  • Bioprinting
  • Bioprocessing
  • Blood
  • Cancer
  • Cardiovascular
  • Cell Therapy
  • Clinical
  • Dermal and Wound
  • Diabetes
  • Drug Screening
  • Exosomes / Extracellular Vesicles
  • Gene Editing
  • Genetic
  • Immunomodulation
  • Lung
  • MedTech, Devices, & Materials
  • Orthopedic
  • Pain
  • Pulmonary
  • Renal
  • Tech Segment
  • Therapeutic Indication
  • Tissue Engineering

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2026 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email